XML 45 R24.htm IDEA: XBRL DOCUMENT v3.25.1
Insider Trading Arrangements
 3 Months Ended
Mar. 31, 2025
shares
Trading Arrangements, by Individual  
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
Donald E. Bobo Jr. [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On February 27, 2025, Donald E. Bobo, Jr., Corporate Vice President, Strategy & Corporate Development, entered into a Plan providing for the potential sale of 66,650 shares of the Company’s stock commencing June 2, 2025. Mr. Bobo's Plan terminates on the earlier of April 16, 2026, or the date all shares are sold.
Name Donald E. Bobo, Jr.
Title Corporate Vice President, Strategy & Corporate Development
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 27, 2025
Expiration Date April 16, 2026
Arrangement Duration 318 days
Aggregate Available 66,650
Larry L. Wood [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On February 27, 2025, Larry L. Wood, Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement (TAVR) and Surgical Structural Heart, entered into a Plan providing for the potential sale of 53,700 shares of the Company’s stock commencing May 30, 2025. Mr. Wood's Plan terminates on the earlier of April 16, 2026, or the date all shares are sold.
Name Larry L. Wood
Title Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement (TAVR) and Surgical Structural Heart
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 27, 2025
Expiration Date April 16, 2026
Arrangement Duration 321 days
Aggregate Available 53,700
Bernard J. Zovighian [Member]  
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
On February 28, 2025, Bernard J. Zovighian, Chief Executive Officer and Director, entered into a Plan providing for the sale of an estimated 62,833* shares of the Company’s stock commencing May 30, 2025. Mr. Zovighian's Plan terminates on the earlier of February 9, 2026, or the date all shares are sold.
*    This is an estimate of the number of shares to be sold under the Plan, which are subject to the conditions of the plan.
Name Bernard J. Zovighian
Title Chief Executive Officer and Director
Rule 10b5-1 Arrangement Adopted true
Adoption Date February 28, 2025
Expiration Date February 9, 2026
Arrangement Duration 255 days
Aggregate Available 62,833